Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment

Published:2006-01 Issue:8 Volume:47 Page:1535-1544
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kutikova Lucie,Bowman Lee,Chang Stella,Long Stacey R.,Arning Michael,Crown William H.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600573325

Reference21 articles.

1. Global Cancer Statistics, 2002

2. American Cancer Society. Cancer facts and figures 2005. American Cancer Society. 2005, Available from: http://www.cancer.org

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results;Journal of Medical Economics;2024-02-13

2. An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States;Journal of Medical Economics;2023-12-19

3. Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data;Journal of Managed Care & Specialty Pharmacy;2023-05

4. Epidemiological and Disease Burden Profiles of Leukemias and Malignant Lymphomas: Overview and Trends in the Republic of Moldova and Worldwide;International Journal of Clinical Medicine;2023

5. The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial;Transplantation and Cellular Therapy;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3